Patent · US Expired

Tumor-associated antigen (R11)

US6809179B1 · kind B1 · utility

6Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2000
Grant dateOct 26, 2004
Priority date
Expiry dateAug 3, 2020

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/828
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Tumor-associated antigens, immunogenic peptides derived therefrom and DNA molecules coding therefor, and the use thereof in the immunotherapy of cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.